(Q41431049)

30 September 2017

1 reference

title

Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy (English)

1 reference

30 September 2017

1 reference

Bretzel RG

1

1 reference

30 September 2017

publication date

1 March 1997

1 reference

Journal of Diabetes and its Complications

30 September 2017

published in

1 reference

30 September 2017

volume

11

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

112-122

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

30 September 2017

1 reference

7 January 2021

Rising incidence of IDDM in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Estimation of the incidence of diabetes in the Federal Republic of Germany based on insurance data. A secondary data analysis of a representative random sample of locally insured persons in the city of Dortmund

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Diabetes mellitus accounts for an ever-increasing proportion of the patients admitted for renal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Uncontrolled hypertension is associated with a rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Statement on hypertension in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Diabetic nephropathy: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Mechanisms of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Transforming growth factor-beta regulates production of proteoglycans by mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Diabetic control and microvascular complications: the near-normoglycaemic experience

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Relation between serum cholesterol and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Partial remission of nephrotic syndrome in patient on long-term simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Restriction of dietary protein and progression of renal failure in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effect of Dietary Protein Restriction on Proteinuria in Non-Insulin-Dependent Diabetic Patients with Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Smoking is associated with progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Relationship between blood pressure and urinary albumin excretion rate in young Danish type 1 diabetic patients: comparison to non-diabetic children. Danish Study Group of Diabetes in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Acute reduction of arterial blood pressure reduces urinary albumin excretion in Type 1 (insulin-dependent) diabetic patients with incipient nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Microalbuminuria in patients with NIDDM: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Proteinuria--a direct cause of renal morbidity?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Postprandial hyperinsulinemia in patients with mild essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effects of Antihypertensive Treatment on Insulin Sensitivity With Special Reference to ACE Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Drug Treatment of Hypertension in Patients With Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Hypertension and micro-albuminuria in diabetic patients taking indapamide

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Nephroprotective effects of nitrendipine in hypertensive type I and type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Renal protective effect of enalapril in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Comparative effects of different antihypertensive treatments on progression of diabetic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Hypertension in diabetic patients. An overview of interventional studies to preserve renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2896%2900105-5

7 January 2021

10.1016/S1056-8727(96)00105-5

Identifiers

DOI

1 reference

30 September 2017

1 reference